Acupuncture as a adjuvant treatment for ischemic stroke--A Multicenter, Randomized Controlled Trial

Not Applicable

• Conditions: Ischemic Stroke

• Registration Number: ITMCTR2200005512
• Lead Sponsor: The first affiliated Hospital of Guangzhou University of Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1.Patients 3-14 days after ischemic stroke;
2.18-75 years old Patients;
3.Clear consciousness, stable vital signs, no obvious mental retardation, Mini-Mental State Examination score in the normal range (normal boundary value: illiteracy > 17, primary school > 20, junior high school and above > 24), can cooperate with acupuncture, rehabilitation training and related basic treatment;
4.The score of modified Rankin scale (mRS) before stroke was less than 1, and the score of National Institutes of Health Stroke scale (NIHSS) after stroke was 5-15.
5.Those who understand the test and sign the informed consent form.

Exclusion Criteria

1.Transient ischemic attack, reversible neurological deficit;
2.Patients confirmed by examination that the life expectancy of patients with neurological impairment caused by brain tumor, brain trauma, cerebral hemorrhage, cerebral parasite and other causes other than stroke is less than 1 year.
3.Patients with acupuncture contraindications, or stroke patients with severe primary diseases such as circulatory system, respiratory system, digestive system, urinary system, endocrine system and hematopoietic system, which can not be controlled by routine medication; patients with tumors, patients with severe infection, water, electrolyte and acid-base balance disorders, or other abnormal researchers judged to be unsuitable to participate in this trial.
4.Those with severe aphasia, sleep apnea, deafness, severe cognitive impairment and inability to communicate normally; or those who are participating in other clinical trials;
5.Patients with severe depression, anxiety, or other mental disorders;
6.Woman who is pregnant or plans to become pregnant.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
mRS;

Secondary Outcome Measures

Name	Time	Method
MBI;MAS;FMA;NIHSS;MRI;